Kukje Pharma Co., Ltd. (KRX:002720)
South Korea
· Delayed Price · Currency is KRW 4,995.00
-15.00 (-0.30%)
Feb 20, 2025, 9:00 AM KST
Kukje Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 19, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 102,220 | 119,890 | 106,115 | 112,861 | 176,865 | 81,078 | Upgrade
|
| Market Cap Growth | 41.18% | 12.98% | -5.98% | -36.19% | 118.14% | 8.62% | Upgrade
|
| Enterprise Value | 123,194 | 140,751 | 127,215 | 143,804 | 207,752 | 109,723 | Upgrade
|
| Last Close Price | 5020.00 | 5920.00 | 5238.10 | 5569.16 | 8724.76 | 3999.57 | Upgrade
|
| PE Ratio | 24.85 | - | 29.83 | - | 80.28 | - | Upgrade
|
| PS Ratio | 0.68 | 0.89 | 0.84 | 0.94 | 1.36 | 0.73 | Upgrade
|
| PB Ratio | 1.14 | 1.41 | 1.43 | 1.65 | 2.51 | 1.33 | Upgrade
|
| P/TBV Ratio | 1.24 | 1.43 | 1.45 | 1.67 | 2.54 | 1.35 | Upgrade
|
| P/FCF Ratio | 91.22 | 47.40 | 20.23 | 14.65 | - | - | Upgrade
|
| P/OCF Ratio | 29.21 | 33.53 | 16.32 | 11.76 | 34.68 | 22.50 | Upgrade
|
| EV/Sales Ratio | 0.82 | 1.04 | 1.00 | 1.20 | 1.59 | 0.99 | Upgrade
|
| EV/EBITDA Ratio | 16.00 | 63.54 | 13.03 | 52.42 | 21.49 | 12.45 | Upgrade
|
| EV/EBIT Ratio | 28.37 | - | 24.13 | - | 34.39 | 19.73 | Upgrade
|
| EV/FCF Ratio | 109.94 | 55.65 | 24.25 | 18.66 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.36 | 0.39 | 0.52 | 0.54 | 0.58 | Upgrade
|
| Debt / EBITDA Ratio | 3.84 | 13.84 | 2.93 | 13.12 | 3.94 | 4.04 | Upgrade
|
| Debt / FCF Ratio | 26.37 | 12.12 | 5.45 | 4.67 | - | - | Upgrade
|
| Asset Turnover | 1.00 | 0.90 | 0.92 | 0.84 | 0.93 | 0.85 | Upgrade
|
| Inventory Turnover | 3.32 | 3.13 | 3.27 | 3.42 | 3.43 | 3.78 | Upgrade
|
| Quick Ratio | 1.25 | 0.53 | 0.54 | 0.58 | 0.51 | 0.74 | Upgrade
|
| Current Ratio | 2.26 | 0.92 | 1.01 | 0.88 | 0.90 | 1.03 | Upgrade
|
| Return on Equity (ROE) | 5.28% | -10.58% | 4.97% | -2.24% | 3.34% | -7.35% | Upgrade
|
| Return on Assets (ROA) | 1.80% | -0.83% | 2.38% | -0.73% | 2.69% | 2.67% | Upgrade
|
| Return on Capital (ROIC) | 2.51% | -1.14% | 3.18% | -0.98% | 3.68% | 3.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.13% | - | 5.94% | - | 6.69% | 7.38% | Upgrade
|
| Earnings Yield | 4.02% | -7.02% | 3.35% | -1.38% | 1.25% | -5.87% | Upgrade
|
| FCF Yield | 1.10% | 2.11% | 4.94% | 6.83% | -3.67% | -2.82% | Upgrade
|
| Buyback Yield / Dilution | -0.39% | 0.03% | 0.03% | 0.02% | 0.00% | 0.02% | Upgrade
|
| Total Shareholder Return | -0.39% | 0.03% | 0.03% | 0.02% | 0.00% | 0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.